drug discovery

Researchers have used artificial intelligence techniques to massively accelerate the search for Parkinson’s disease treatments.

Researchers have developed a platform that combines automated experiments with AI to predict how chemicals will react with one another, which could...

Researchers have developed a method to identify new targets for human disease, including neurodegenerative conditions such as Alzheimer’s disease.

Vector Bioscience has received a £2.2 million investment to help it take forward its drug delivery platform designed to make RNA cancer therapies...

Cambridge's Experimental Medicine Initiative, working with AstraZeneca and GSK, is training specialists who can work out at an earlier stage of...

Researchers have developed a new approach to machine learning that ‘learns how to learn’ and out-performs current machine learning methods for drug...

Cambridge scientists have identified 200 approved drugs predicted to work against COVID-19 – of which only 40 are currently being tested in COVID-19...

Three companies, Astex Pharmaceuticals, Eisai Ltd and Eli Lilly and Company, are joining forces with research scientists across Cambridge to explore...